Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Research square·2026
Same author

Emerging roles and regulatory mechanisms involved in glutamine metabolism.

Trends in biochemical sciences·2026
Same author

Ras promotes macropinocytic nutrient uptake by suppressing the albumin recycling receptor FcRn.

EMBO reports·2026
Same author

Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibility.

bioRxiv : the preprint server for biology·2026
Same author

Temporal regulation of human reactive astrocytes reveals their capacity for antigen presentation.

Neuron·2026
Same author

Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.

Nature·2026
Same journal

Basic Microglial Functions and How They Go Awry in Neurodegenerative Disease.

Annual review of pathology·2026
Same journal

Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas.

Annual review of pathology·2025
Same journal

The Role of Fibroblasts Across Inflammation and Immunity.

Annual review of pathology·2025
Same journal

The Role of MicroRNAs in Viral and Bacterial Infections.

Annual review of pathology·2025
Same journal

Role of Immune Cells in Hepatitis B Virus and Associated Sequelae.

Annual review of pathology·2025
Same journal

Pathology of the Coronary Arteries and Myocardium in Kawasaki Disease.

Annual review of pathology·2025
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

567

Metabolic Reprogramming in Brain Tumors.

Sriram Venneti1, Craig B Thompson2

  • 1Department of Pathology, University of Michigan, Ann Arbor, Michigan, 48109;

Annual Review of Pathology
|January 10, 2017
PubMed
Summary
This summary is machine-generated.

Genetic alterations in primary brain tumors reprogram cellular metabolism, impacting tumor growth, epigenetics, and drug resistance. Understanding these metabolic shifts offers new diagnostic and therapeutic strategies for brain cancer.

Keywords:
IDH mutationgliomaglucoseglutamineimagingtreatment

More Related Videos

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.3K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K

Related Experiment Videos

Last Updated: Mar 9, 2026

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

567
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.3K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Metabolic Reprogramming

Background:

  • Next-generation sequencing (NGS) has identified novel genetic alterations in primary brain tumors.
  • The precise role of these genetic changes in brain tumor pathogenesis remains unclear.
  • Emerging evidence links oncogenes to the reprogramming of cellular metabolism for tumor survival and proliferation.

Purpose of the Study:

  • To discuss how genetic alterations in brain tumors rewire cellular metabolism.
  • To explore the impact of metabolic reprogramming on epigenetics and the tumor microenvironment.
  • To highlight the potential of targeting altered metabolism for diagnosis and therapy.

Main Methods:

  • Review of current literature on genetic alterations and metabolic reprogramming in brain tumors.
  • Analysis of the interplay between genetic drivers, metabolism, epigenetics, and the tumor microenvironment.
  • Discussion of metabolic alterations as biomarkers for imaging and therapeutic targets.

Main Results:

  • Specific genetic alterations in brain tumors are shown to rewire cellular metabolism.
  • Metabolic reprogramming influences epigenetic modifications beyond classical tumor pathogenesis.
  • The tumor microenvironment significantly impacts metabolic alterations, contributing to drug resistance and recurrence.

Conclusions:

  • Altered cancer metabolism in brain tumors presents novel therapeutic opportunities.
  • Leveraging metabolic changes can improve noninvasive imaging for diagnosis and treatment evaluation.
  • Targeting metabolic reprogramming offers a promising avenue for effective primary brain tumor treatment.